TALARIS THERAPEUTICS INC (TALS) Stock Analyst Ratings
NASDAQ:TALS - Nasdaq - US87410C1045 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to TALS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.4. This target is 650% above the current price.
TALS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TALS.
In the previous month the buy percentage consensus was at a similar level.
TALS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-17 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-02-23 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-24 | HC Wainwright & Co. | Maintains | Buy |
| 2022-10-20 | SVB Leerink | Maintains | Market Perform |
| 2022-10-20 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-07-05 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-07-01 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-24 | Morgan Stanley | Maintains | Overweight |
| 2022-05-13 | SVB Leerink | Maintains | Outperform |
| 2021-11-12 | SVB Leerink | Maintains | Outperform |
| 2021-06-01 | Guggenheim | Initiate | Buy |
| 2021-06-01 | SVB Leerink | Initiate | Outperform |
| 2021-06-01 | Evercore ISI Group | Initiate | Outperform |
| 2021-06-01 | Morgan Stanley | Initiate | Overweight |